<- Go Home
EMIS Group plc
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.
Market Cap
GBP 1.2B
Volume
678.4K
Cash and Equivalents
GBP 48.5M
EBITDA
GBP 35.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 87.7M
Profit Margin
49.60%
52 Week High
GBP 19.44
52 Week Low
GBP 12.50
Dividend
N/A
Price / Book Value
9.16
Price / Earnings
40.44
Price / Tangible Book Value
107.39
Enterprise Value
GBP 1.2B
Enterprise Value / EBITDA
31.99
Operating Income
GBP 29.3M
Return on Equity
23.17%
Return on Assets
7.99
Cash and Short Term Investments
GBP 48.5M
Debt
GBP 3.9M
Equity
GBP 132.4M
Revenue
GBP 176.9M
Unlevered FCF
GBP 42.7M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium